Click image to zoom

Lancet Surgisphere Hydroxychloroquine Study

The webpage on the medical journal The Lancet of a now-retracted study on anti-malarial drug hydroxychloroquine as treatment for COVID-19 is seen on a mobile phone in Manila, Philippines on Wednesday, 23 September 2020. Leading medical journal The Lancet announced changes to its editorial policy after retracting a study by Surgisphere on the adverse effects of hydroxychloroquine as treatment for COVID-19 after its authors found lapses on the data gathered by the US healthcare analytics company. (Photo Illustration by Richard James Mendoza/NurPhoto)

Photo Details

Photo ID	#6025002
Date Taken	23 September 2020
Location	N/A
Photographer	Richard James Mendoza/NurPhoto
Category	Politics
Copyright	© 2025 NurPhoto - Richard James Mendoza/NurPhoto

Related Keywords

treatment COVID Leading medical journal retracted study Lancet announced changes adverse effects of hydroxychloroquine anti-malarial drug hydroxychloroquine editorial policy data Richard James Mendoza Surgisphere Photo Illustration NurPhoto US healthcare analytics company mobile phone Manila Philippines authors webpage No People Text Font

License This Photo

Digital Basic Editorial use on digital platforms only (websites, social media). Single use, up to 1 million monthly UVs. Worldwide distribution. NO COMMERCIAL OR PROMOTIONAL USE

€35.00

Editorial Print & Digital For editorial use in print and digital publications such as newspapers, magazines, and textbooks. Single use, up to 10,000 copies or 1 million UVs. Worldwide distribution. NO COMMERCIAL OR PROMOTIONAL USE

€99.00

Broadcast (TV & Digital) For editorial use in TV production or streaming platforms. Single use, all media rights excluding theatrical, with worldwide distribution in perpetuity. NO COMMERCIAL OR PROMOTIONAL USE

€399.00

Total Price

€35.00

Secure checkout

Need a custom license?

Contact Sales